Episode Details
Back to Episodes
Solventum Q1 Earnings: Beating Expectations
Published 2 days, 5 hours ago
Description
Solventums Q1 earnings beat expectations with $2.01 billion revenue, $1.48 EPS, and $468.8 million EBITDA, driven by advanced wound care, dental products, and health info systems. Despite organic revenue growth missing the mark and operating margins dipping, they maintained full-year EPS guidance. Investors watch for ERP cutovers, new product launches, and cost-saving programs, with the stock at around $72.
Support the show:
Get a discount at https://solipillow.com/discount/dnn.
Advertise on DNN:
advertise@thednn.ai
This is an automated, high-level news summary based on public reporting.
Report issues to feedback@thednn.ai.
View sources & latest updates:
https://sources.thednn.ai/9b4cb8a58d94e0fd